Cygnetise applies blockchain technology to transform the process of Authorised Signatory Management. The platform reduces the risk of fraud, transforms operations and strengthens governance by enabling operations and finance departments to digitally manage and share authorised signatories in real time with their banks and other counterparties.

Adjuvo is delighted to have invested alongside US firm, Massive, and existing VC and angel investors.

Adjuvo CEO, Mark Foster-Brown, commented, “As many Adjuvo members know from personal experience, Authorised Signatory Management is a business-critical process for most companies worldwide and particularly in financial and legal services. Cygnetise is transforming this currently manual exercise with their digital blockchain technology, leading to increased efficiency, security and operational excellence. The need is both real and obvious, and so we are delighted to lead this round to support Steve and the team as they drive an ambitious growth strategy. We look forward to introducing them to our extensive network of British business leaders.”